Overview

Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial

Status:
Not yet recruiting

Trial end date:
2026-07-30

Target enrollment:

Participant gender:

Summary

The main objective is to evaluate the effectiveness of Rituximab monotherapy versus steroid therapy on children with new-onset nephrotic syndrome within the 52-week follow-up.

Phase:

Phase 3

Details

Lead Sponsor:

The Children's Hospital of Zhejiang University School of Medicine

Treatments:

Rituximab